1. A method of treating a broncho-constrictive condition, comprising the act of administering to a subject in need thereof a composition comprising pentameric procyanidin type A at a concentration ranging from about 55% w / w. up to about 99% w / w, trimeric procyanidin and tetrameric procyanidin, each in a concentration ranging from about 0.5% w / w. up to about 35% w / w. possibly together with one or more than one pharmaceutical excipient in a concentration ranging from about 0.5% to about 99.9%. 2. The method of claim 1, wherein said bronchial constrictive condition is selected from the group consisting of allergic rhinitis, asthma, and chronic obstructive pulmonary disease, or any combination thereof. The method according to claim 1, where the pentameric procyanidin type A is in a concentration ranging from about 80% wt./wt. to about 90% w / w, each of the trimeric procyanidin and tetrameric procyanidin is in a concentration ranging from about 0.5% w / w. up to about 20% w / w. 4. The method according to claim 1, where the pharmaceutical excipient is selected from the group consisting of gums, granulating agents, binders, lubricants, disintegrants, sweeteners, additives, solvents, glidants, anti-adhesive agents, antistatic agents, surfactants, antioxidants, surfactants active substances, viscosity enhancers, dyes based on plant cellulosic material, flavoring agents, coating substances, plasticizers, preservatives, suspending agents, emulsifiers and sphere forming agents, or their any combinations. 5. The method according to claim 1, where the composition is prepared in the form of a preparation in dosage forms, �1. Способ терапии бронхо-констриктивного состояния, включающий акт введения субъекту, нуждающемуся в этом, композиции, содержащей пентамерный процианидин типа А в концентрации, варьирующей от примерно 55% мас./мас. до примерно 99% мас./мас., тримерный процианидин и тетрамерный процианидин, каждый в концентрации, варьирующей от примерно 0,5% мас./мас. до